Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26928811 |
US |
76 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 102 | 26928821 |
US |
40 | 2 |
Asthma, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 103 | 26928830 |
US |
15 | 2 |
Sleep disorder due to a general medical condition, Rash, Skin discomfort, Dermatitis atopic, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 104 | 26928838 |
US |
57 | 2 |
Asthma, Heart rate increased, Anxiety, Nerve injury, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 105 | 26929118 |
CA |
2 | |
Bronchitis, Asthma, Pneumonia, Pneumothorax, Nephrolithiasis, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, OMALIZUMAB, BOSENTAN, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, LORAZEPAM, QUETIAPINE, RABEPRAZOLE, |
||||
| 106 | 26929144 |
CA |
61 | 2 |
Angina pectoris, Appetite disorder, Asthma, Chest discomfort, Chest pain, Cough, Depressed mood, Depressive symptom, Dyspnoea, Dyspnoea exertional, Fall, Flank pain, Heart sounds, Influenza, Injury, Insomnia, Loss of personal independence in daily activities, Lower respiratory tract infection, Malaise, Nasal congestion, Nasopharyngitis, Productive cough, Prolonged expiration, Pyrexia, Rales, Respiration abnormal, Rhinorrhoea, Sleep disorder due to a general medical condition, Stress, Upper respiratory tract infection, Weight decreased, Wheezing, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, DIMENHYDRINATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FUROSEMIDE, NITROGLYCERIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOMETASONE, MOMETASONE, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROGLYCERIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, QUINAPRIL, QUINAPRIL HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, |
||||
| 107 | 26929918 |
US |
69 | 2 |
Viral infection, Asthma, |
||||
DUPILUMAB, |
||||
| 108 | 26930018 |
US |
||
Asthma, Dental caries, Tooth demineralisation, Alopecia, |
||||
BRENSOCATIB, |
||||
| 109 | 26930137 |
GB |
1 | |
Respiratory failure, Asthma, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DUPILUMAB, ALLOPURINOL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 110 | 26930192 |
US |
2 | |
Asthma, Product dose omission issue, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 111 | 26930276 |
CA |
32 | 2 |
Pneumonia, Heart rate increased, Tachycardia, Sinusitis, Anxiety, Fungal infection, Product administration error, Bacterial infection, Eosinophil count abnormal, Musculoskeletal chest pain, Migraine, Rhinitis, Oropharyngeal pain, Asthma, Infection, Restrictive pulmonary disease, Terminal insomnia, Middle insomnia, Dyspnoea exertional, Malaise, Psoriasis, Eczema, Abdominal pain, Dyspnoea, Obstructive airways disorder, Urinary tract infection, Sleep disorder, Therapeutic response decreased, Upper-airway cough syndrome, Nasopharyngitis, Loss of personal independence in daily activities, Influenza, Sleep disorder due to a general medical condition, Vertigo, Pain, Productive cough, Tooth abscess, Rales, Forced expiratory volume decreased, Drug ineffective, Dizziness, Nasal congestion, Therapeutic product effect decreased, Full blood count abnormal, Cough, Vomiting, Diarrhoea, Blood pressure increased, Nasal discharge discolouration, Wheezing, Ear infection, Decreased activity, Emphysema, Stress, Feeding disorder, Urticaria, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MONTELUKAST SODIUM, MONTELUKAST, TERBUTALINE SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, IPRATROPIUM BROMIDE, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, CICLESONIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, QUETIAPINE FUMARATE, QUETIAPINE, MONTELUKAST SODIUM, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, EPINEPHRINE, EPINEPHRINE, |
||||
| 112 | 26930635 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Wheezing, Drug hypersensitivity, Dyspnoea, Vomiting, |
||||
OMALIZUMAB, OMALIZUMAB, RITUXIMAB, CLONAZEPAM, AZITHROMYCIN MONOHYDRATE, CEFADROXIL, CEFADROXIL, CEFADROXIL, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, ALBUTEROL SULFATE, |
||||
| 113 | 26930666 |
2 | ||
Asthma, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 114 | 26930696 |
US |
2 | |
Asthma, Cough, Device malfunction, Vision blurred, Device use error, Product delivery mechanism issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 115 | 26921516 |
US |
33 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, |
||||
| 116 | 26921698 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 117 | 26921701 |
US |
2 | |
Fatigue, Asthma, |
||||
DUPILUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, |
||||
| 118 | 26921706 |
US |
39 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 119 | 26921719 |
US |
42 | 2 |
Respiratory tract infection, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, SODIUM FLUORIDE, STANNOUS FLUORIDE RINSE, MONTELUKAST SODIUM, MONTELUKAST, TOPIRAMATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 120 | 26921812 |
US |
2 | |
Lymphadenopathy, Escherichia urinary tract infection, Asthma, Chronic obstructive pulmonary disease, |
||||
RAVULIZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 121 | 26922019 |
US |
45 | 1 |
Wheezing, Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, PREDNISONE, PREDNISONE, PANTOPRAZOLE, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, METHOCARBAMOL, METHOCARBAMOL TABLETS, MELOXICAM, BENRALIZUMAB, BUDESONIDE, BENZONATATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 122 | 26922044 |
CA |
72 | 1 |
Anxiety, Arteriosclerosis, Arteriosclerosis coronary artery, Asthma, Condition aggravated, Conjunctivitis allergic, Dust allergy, Dyspnoea, Haemoptysis, Hypothyroidism, Hypoxia, Lung disorder, Mite allergy, Mycotic allergy, Neuritis, Neurological symptom, Nodule, Normochromic normocytic anaemia, Obstructive airways disorder, Pain in extremity, Productive cough, Pulmonary alveolar haemorrhage, Eosinophilic granulomatosis with polyangiitis, Forced expiratory volume decreased, Pulmonary embolism, Pulmonary fibrosis, Pulmonary vasculitis, Respiratory symptom, Skin exfoliation, Sleep disorder due to a general medical condition, Thrombosis, Vasculitis, Wheezing, Antineutrophil cytoplasmic antibody positive, Full blood count abnormal, Product use in unapproved indication, Spirometry abnormal, Total lung capacity abnormal, Therapeutic product effect incomplete, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, APIXABAN, BUDESONIDE, BUDESONIDE, BUDESONIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CICLESONIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, MAGNESIUM OXIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOMETASONE, MEPOLIZUMAB, CICLESONIDE, CICLESONIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, APIXABAN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 123 | 26922078 |
CA |
60 | 1 |
Asthma, Cough, Disease recurrence, Drug dependence, Dyspnoea, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Full blood count abnormal, Gastrooesophageal reflux disease, Haemoptysis, Hypoaesthesia, Malaise, Neuropathy peripheral, Paraesthesia, Productive cough, Therapeutic product effect incomplete, Upper respiratory tract infection, Vasculitis, Visual impairment, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, RANIBIZUMAB, RANIBIZUMAB, MOMETASONE, MOMETASONE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 124 | 26922169 |
US |
2 | |
Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 125 | 26922175 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, IRBESARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TIRZEPATIDE, ROSUVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 126 | 26923085 |
US |
61 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 127 | 26923752 |
US |
53 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 128 | 26923762 |
BR |
2 | |
Near death experience, Drug dependence, Panic attack, Agitation, Psychomotor hyperactivity, Cardiac disorder, Fall, Asthma, Influenza, Wrong product administered, Prescription drug used without a prescription, Paraesthesia, Cold sweat, Feeling abnormal, Decreased appetite, General physical health deterioration, Anger, Poor quality sleep, Social anxiety disorder, Neurotransmitter level altered, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, |
||||
| 129 | 26923773 |
JP |
26 | 1 |
Anaphylactic reaction, Seizure, Asthma, Tremor, Erythema, Pruritus, Flushing, Body temperature increased, |
||||
DUPILUMAB, |
||||
| 130 | 26923789 |
JP |
71 | 2 |
Asthma, Pneumonia, |
||||
BENRALIZUMAB, BENRALIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, MONTELUKAST, CLARITHROMYCIN, |
||||
| 131 | 26924066 |
CA |
59 | 2 |
Pericarditis, Retinitis, Malaise, Fibromyalgia, Hypersensitivity, Alopecia, Headache, Blister, Lupus vulgaris, Joint swelling, Glossodynia, Arthropathy, Anxiety, Pemphigus, Hand deformity, Arthralgia, Decreased appetite, Fatigue, Duodenal ulcer perforation, Blood cholesterol increased, Rheumatic fever, Asthma, Hepatic enzyme increased, Discomfort, Rash, Hypertension, Hypercholesterolaemia, Injury, General physical health deterioration, Diarrhoea, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CERTOLIZUMAB PEGOL, SARILUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, USTEKINUMAB, USTEKINUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ALENDRONATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 132 | 26924235 |
US |
2 | |
Asthma, Cough, Dyspnoea, Productive cough, |
||||
BRENSOCATIB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, ALPRAZOLAM, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, MAGNESIUM OXIDE, POLYETHYLENE GLYCOL 3350, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, RABEPRAZOLE, ROSUVASTATIN, CYCLOSPORINE OPHTHALMIC SOLUTION, ASCORBIC ACID, |
||||
| 133 | 26925437 |
US |
53 | 1 |
Eosinophilic oesophagitis, Dermatitis, Asthma, Rash erythematous, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 134 | 26925451 |
US |
62 | 2 |
Bronchitis, Asthma, Dyspnoea, Injection site swelling, Injection site pain, |
||||
DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE AND BUDESONIDE, AMLODIPINE BESYLATE, CALCIUM, FISH OIL, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, MONTELUKAST SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, VITAMIN E, |
||||
| 135 | 26926104 |
CA |
34 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
AMLODIPINE BESYLATE, CLONAZEPAM, ERGOCALCIFEROL, RISEDRONATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CALCIUM, MONTELUKAST, OMALIZUMAB-IGEC, PREDNISONE, RITUXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ROSUVASTATIN CALCIUM, CEFADROXIL, NEOMYCIN OINTMENT, POLYMYXIN B SULFATE, |
||||
| 136 | 26926543 |
US |
61 | 2 |
Asthma, Infection, |
||||
DUPILUMAB, |
||||
| 137 | 26930308 |
81 | 2 | |
Asthma, Arteriosclerosis, Arterial occlusive disease, Sciatica, Treatment delayed, |
||||
DENOSUMAB, |
||||
| 138 | 26914644 |
US |
1 | |
Asthma, Infusion site infection, Infusion site reaction, Infusion site pruritus, Infusion site rash, Infusion site erythema, Infusion site swelling, Infusion site pain, |
||||
FOSCARBIDOPA/FOSLEVODOPA, ALBUTEROL SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, |
||||
| 139 | 26915293 |
CA |
59 | 2 |
Duodenal ulcer perforation, Product use in unapproved indication, Type 2 diabetes mellitus, Maternal exposure during pregnancy, Pericarditis, Therapeutic product effect decreased, Treatment failure, Diarrhoea, Adverse event, Oedema peripheral, Drug ineffective, Psoriatic arthropathy, Nasopharyngitis, Pain in extremity, Hand deformity, Rheumatic fever, Malaise, Retinitis, Systemic lupus erythematosus, Fibromyalgia, Anxiety, Lupus vulgaris, Blister, Asthma, Glossodynia, Anti-cyclic citrullinated peptide antibody positive, Discomfort, Arthralgia, Hypertension, Bronchitis, Liver injury, Hypercholesterolaemia, Pemphigus, Red blood cell sedimentation rate increased, Wound, Contraindicated product administered, Helicobacter infection, Visual impairment, Musculoskeletal stiffness, Intentional product use issue, Off label use, Hypoaesthesia, Alopecia, Adverse drug reaction, Rash, Mobility decreased, Rheumatoid factor positive, Drug intolerance, Fatigue, Rheumatoid arthritis, Hypersensitivity, Blood cholesterol increased, Hepatic enzyme increased, Headache, Decreased appetite, General physical health deterioration, Joint swelling, Abdominal discomfort, Therapeutic product effect incomplete, Infusion related reaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ERGOCALCIFEROL, USTEKINUMAB, USTEKINUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, ERGOCALCIFEROL, AZATHIOPRINE, HYDROCORTISONE, HYDROCORTISONE, PREDNISONE, PREDNISONE, PHENYLEPHRINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MORPHINE SULFATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, LANSOPRAZOLE, LANSOPRAZOLE, RAMIPRIL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, MINOCYCLINE HYDROCHLORIDE, SARILUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, CALCIUM GLUCONATE, CALCIUM GLUCONATE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, APREMILAST, APREMILAST, DESOXIMETASONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, CERTOLIZUMAB PEGOL, MINOCYCLINE, MINOCYCLINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TELMISARTAN, ABATACEPT, ABATACEPT, ABATACEPT, VITAMIN C, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BUPROPION, LISINOPRIL, LORAZEPAM, LORAZEPAM, ACETAMINOPHEN AND CODEINE, CAFFEINE CITRATE, BUPROPION HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROMORPHONE HYDROCHLORIDE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 140 | 26915297 |
US |
68 | |
Asthma, Injection site pain, |
||||
DUPILUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CYCLOBENZAPRINE, GABAPENTIN, LOSARTAN, MELATONIN, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TIOTROPIUM BROMIDE, CETIRIZINE HCL, CETIRIZINE, MONTELUKAST, |
||||
| 141 | 26915300 |
US |
32 | 2 |
Asthma, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 142 | 26915428 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
RITUXIMAB, RITUXIMAB, CLONAZEPAM, OMALIZUMAB, OMALIZUMAB, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, FOLIC ACID, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, RISEDRONATE SODIUM, TRAMADOL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BECLOMETHASONE DIPROPIONATE, ROSUVASTATIN, ERGOCALCIFEROL, |
||||
| 143 | 26915541 |
US |
2 | |
Feeling abnormal, Asthma, |
||||
OSELTAMIVIR PHOSPHATE, |
||||
| 144 | 26915622 |
JP |
2 | |
Asthma, Dysphonia, Productive cough, Lung disorder, Respiratory muscle weakness, Wrong technique in product usage process, |
||||
| 145 | 26915818 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
PROPRANOLOL HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE BESYLATE, CALCIUM, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ROSUVASTATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, |
||||
| 146 | 26915839 |
US |
59 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 147 | 26915941 |
US |
39 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 148 | 26916322 |
US |
62 | 2 |
Asthma, Dyspnoea, Wheezing, Rhinorrhoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 149 | 26916350 |
US |
50 | 2 |
Asthma, Dyspnoea, Headache, Injection site rash, Nausea, Rash, |
||||
ABATACEPT, |
||||
| 150 | 26916412 |
US |
1 | |
Asthma, |
||||
VENETOCLAX, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OLMESARTAN MEDOXOMIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, AMOXICILLIN, VALSARTAN, VALSARTAN ORAL, LEUPROLIDE ACETATE, |
||||
| 151 | 26916475 |
US |
2 | |
Asthma, Wrong technique in device usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 152 | 26916581 |
CA |
74 | 2 |
Rheumatoid arthritis, Oropharyngeal pain, Throat irritation, Limb injury, Fall, Pain in extremity, Asthma, Product dose omission issue, Candida infection, Skin exfoliation, Oral pain, Alopecia, Asthenia, Weight increased, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, PREDNISONE, LEFLUNOMIDE, RISEDRONATE SODIUM, ERGOCALCIFEROL, CYCLOBENZAPRINE, ESOMEPRAZOLE MAGNESIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FOLIC ACID, ALBUTEROL SULFATE, |
||||
| 153 | 26916614 |
US |
53 | 2 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 154 | 26917177 |
US |
2 | |
Pneumonia, Asthma, Off label use, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 155 | 26917309 |
US |
70 | 2 |
Sleep disorder due to a general medical condition, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CARVEDILOL, CETIRIZINE HCL, CETIRIZINE, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, LOSARTAN POTASSIUM, LOSARTAN, PREGABALIN, NITROGLYCERIN, ONDANSETRON HYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 156 | 26917319 |
CA |
2 | |
Pneumonia, Road traffic accident, Paralysis, Asthma, Weight increased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 157 | 26917447 |
US |
2 | |
Cardiac neoplasm unspecified, Asthma, |
||||
| 158 | 26917504 |
US |
2 | |
Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 159 | 26918223 |
CA |
43 | 2 |
Breast cancer stage II, Asthenia, Dislocation of vertebra, Arthralgia, Gait inability, Malaise, Fluid retention, Rheumatoid factor positive, Urticaria, Joint swelling, Synovitis, Asthma, Hand deformity, Mobility decreased, Decreased appetite, Systemic lupus erythematosus, Wound, Rheumatoid arthritis, Lower limb fracture, Injury, Drug hypersensitivity, Road traffic accident, Musculoskeletal pain, Pemphigus, Blood cholesterol increased, Sciatica, Drug intolerance, Liver disorder, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, OXYCODONE, OXYCODONE, |
||||
| 160 | 26918363 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
OMALIZUMAB, RITUXIMAB, CLONAZEPAM, MONTELUKAST, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, AMLODIPINE, MOXIFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, PREDNISOLONE SODIUM PHOSPHATE, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, RISEDRONATE SODIUM, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, BECLOMETHASONE DIPROPIONATE, CALCIUM, ROSUVASTATIN, TRAMADOL HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 161 | 26918733 |
60 | ||
Asthma, |
||||
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, |
||||
| 162 | 26919346 |
US |
67 | 2 |
Asthma, Urticaria, Drug withdrawal headache, Eye irritation, |
||||
ACOLTREMON, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 163 | 26920811 |
US |
74 | 2 |
Throat tightness, Asthma, |
||||
ACOLTREMON, |
||||
| 164 | 26920942 |
CA |
65 | 1 |
Anxiety, Antineutrophil cytoplasmic antibody positive, Arteriosclerosis, Arteriosclerosis coronary artery, Asthma, Capillaritis, Condition aggravated, Conjunctivitis allergic, Dust allergy, Dyspnoea, Eosinophilic granulomatosis with polyangiitis, Forced expiratory volume decreased, Full blood count abnormal, Haemoptysis, Hypothyroidism, Hypoxia, Loss of personal independence in daily activities, Lung disorder, Mite allergy, Mycotic allergy, Neuritis, Neurological symptom, Nodule, Normochromic normocytic anaemia, Obstructive airways disorder, Pain in extremity, Productive cough, Pulmonary alveolar haemorrhage, Pulmonary embolism, Pulmonary fibrosis, Pulmonary vasculitis, Respiratory symptom, Sleep disorder, Sleep disorder due to a general medical condition, Spirometry abnormal, Therapeutic product effect incomplete, Thrombosis, Total lung capacity abnormal, Vasculitis, Wheezing, |
||||
CEPHALEXIN, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, AZATHIOPRINE, AZITHROMYCIN DIHYDRATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CALCIUM CARBONATE, ANTACID, SENNOSIDES, SENNOSIDES, CANDESARTAN, CANDESARTAN, CANDESARTAN, CARBAMAZEPINE, CEFUROXIME, CEFUROXIME, CEFUROXIME, CEFUROXIME, CEFUROXIME, CICLESONIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, DOXAZOSIN MESYLATE, DUTASTERIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, ESCITALOPRAM OXALATE, ESCITALOPRAM, FLUTICASONE PROPIONATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FUROSEMIDE, GLUCAGON, GLUCAGON, HYDROCHLOROTHIAZIDE, AZATHIOPRINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, FUROSEMIDE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIRAGLUTIDE, MAGNESIUM OXIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MEPOLIZUMAB, CICLESONIDE, PANTOPRAZOLE, PENICILLIN G SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, SULFADIAZINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, THIAMINE HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, TRIMETHOPRIM, VITAMIN C, ERGOCALCIFEROL, |
||||
| 165 | 26921044 |
2 | ||
Asthma, |
||||
NALTREXONE, |
||||
| 166 | 26909515 |
US |
69 | 2 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 167 | 26909632 |
US |
||
Asthma, Product odour abnormal, |
||||
MALATHION, IVERMECTIN, CETIRIZINE HYDROCHLORIDE, |
||||
| 168 | 26910090 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LAMOTRIGINE, QUETIAPINE, TAMOXIFEN CITRATE, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 169 | 26910245 |
US |
||
Dyspnoea, Illness, Asthma, Wheezing, |
||||
OMALIZUMAB, |
||||
| 170 | 26910246 |
US |
2 | |
Asthma, Urticaria, |
||||
OMALIZUMAB, |
||||
| 171 | 26910313 |
US |
62 | 2 |
Sleep disorder due to a general medical condition, Asthma, |
||||
DUPILUMAB, |
||||
| 172 | 26910439 |
US |
2 | |
Femur fracture, Asthma, |
||||
| 173 | 26911544 |
US |
34 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 174 | 26911564 |
CO |
2 | |
Asthma, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 175 | 26911585 |
CA |
65 | 2 |
Wheezing, Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, |
||||
ROPIVACAINE HYDROCHLORIDE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, BECLOMETHASONE DIPROPIONATE, CALCIUM CARBONATE, ANTACID, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, CEFADROXIL, CEFADROXIL, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
| 176 | 26911602 |
US |
2 | |
Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 177 | 26911788 |
CO |
64 | 1 |
Asthma, Abdominal distension, Loss of personal independence in daily activities, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 178 | 26911820 |
US |
45 | 1 |
Therapeutic response shortened, Wheezing, Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, PREDNISONE, PANTOPRAZOLE, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, MELOXICAM, BUDESONIDE, BENZONATATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 179 | 26911868 |
US |
65 | 2 |
Urticaria, Asthma, |
||||
ABATACEPT, |
||||
| 180 | 26912357 |
US |
2 | |
Viral infection, Asthma, |
||||
DUPILUMAB, |
||||
| 181 | 26912365 |
US |
1 | |
Asthma, Eczema, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, DEXMETHYLPHENIDATE HYDROCHLORIDE, |
||||
| 182 | 26913061 |
US |
63 | 1 |
Pneumonia, Asthma, |
||||
DUPILUMAB, |
||||
| 183 | 26913184 |
US |
1 | |
Asthma, Drug delivery system issue, |
||||
BECLOMETHASONE DIPROPIONATE HFA, |
||||
| 184 | 26913297 |
CA |
2 | |
General physical health deterioration, Pulmonary fibrosis, Duodenal ulcer perforation, Abdominal discomfort, Alopecia, Arthropathy, Asthma, Autoimmune disorder, Blood cholesterol increased, Chest pain, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Discomfort, Dizziness, Drug intolerance, Dyspepsia, Irritable bowel syndrome, Liver injury, Lower limb fracture, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Pain, Pemphigus, Pericarditis, Pneumonia, Pruritus, Psoriatic arthropathy, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypertension, Hypoaesthesia, Impaired healing, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Road traffic accident, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wound, Prescribed overdose, Drug ineffective, Maternal exposure during pregnancy, Exposure during pregnancy, Contraindicated product administered, Off label use, Product use in unapproved indication, Incorrect route of product administration, Product use issue, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, VITAMIN C, VITAMIN C, VITAMIN C, TOFACITINIB, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 185 | 26913324 |
US |
71 | 2 |
Anaemia, Red blood cell count decreased, Fatigue, Dyspnoea exertional, Loss of personal independence in daily activities, Pain in extremity, Gait disturbance, Hypokinesia, Chronic obstructive pulmonary disease, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 186 | 26913342 |
US |
||
Asthma, Condition aggravated, Product ineffective, Therapy interrupted, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 187 | 26913492 |
CA |
60 | 1 |
Asthma, Cough, Disease recurrence, Drug dependence, Dyspnoea, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Full blood count abnormal, Gastrooesophageal reflux disease, Haemoptysis, Hypoaesthesia, Malaise, Neuropathy peripheral, Paraesthesia, Productive cough, Upper respiratory tract infection, Vasculitis, Therapeutic product effect incomplete, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL SULFATE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MOMETASONE FUROATE, BUDESONIDE, BUDESONIDE, BUDESONIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, GLYCOPYRROLATE, MOMETASONE FUROATE, MOMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 188 | 26914616 |
US |
2 | |
Dementia, Vocal cord paralysis, Asthma, Impaired work ability, Product dose omission issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 189 | 26916776 |
72 | 2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 190 | 26904656 |
US |
74 | 2 |
Pain in extremity, Arthritis, Osteoarthritis, Asthma, |
||||
DUPILUMAB, |
||||
| 191 | 26904733 |
CO |
61 | 1 |
Chronic obstructive pulmonary disease, Asthma, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 192 | 26905253 |
US |
2 | |
Pneumonia, Asthma, Inappropriate schedule of product administration, Drug ineffective, Somnolence, Loss of personal independence in daily activities, Social problem, Exercise tolerance decreased, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 193 | 26905329 |
CA |
74 | 1 |
Death, Asthma, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, |
||||
| 194 | 26905714 |
US |
84 | 2 |
Fall, Dyspnoea, Confusional state, Chest pain, Delirium, Pulmonary oedema, Wheezing, Cough, Asthma, Dyspnoea, Sputum discoloured, Therapy interrupted, Asthenia, Fatigue, Oedema peripheral, Arthritis, Retinal disorder, Generalised oedema, Adverse drug reaction, Insomnia, Stasis dermatitis, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AMLODIPINE, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELASTINE, BACLOFEN, |
||||
| 195 | 26906007 |
US |
67 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 196 | 26906348 |
US |
48 | 2 |
Asthma, Injection site pain, Multiple allergies, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 197 | 26906369 |
CA |
80 | |
Activated partial thromboplastin time prolonged, Anaemia, Aspiration, Asthenia, Asthma, Bacterial infection, Benign prostatic hyperplasia, Blood calcium increased, Blood creatinine increased, Blood test abnormal, Breath sounds abnormal, Bronchopulmonary aspergillosis allergic, Cardiovascular disorder, Chronic obstructive pulmonary disease, Condition aggravated, Congenital hiatus hernia, Coronary artery disease, Diabetes mellitus, Drug hypersensitivity, Drug intolerance, End stage renal disease, Fatigue, Full blood count abnormal, Gastrointestinal disorder, General physical health deterioration, Gout, Headache, Hypercholesterolaemia, Hyperlipidaemia, Hyperphosphataemia, Hypertension, Hyponatraemia, Hypophosphataemia, Joint injury, Liver disorder, Lower respiratory tract infection, Lung disorder, Malignant melanoma stage 0, Micturition urgency, Multiple organ dysfunction syndrome, Musculoskeletal stiffness, Myasthenia gravis, Neuralgia, Oedema peripheral, Pain, Pleuritic pain, Pulmonary embolism, Pyrexia, Respiratory symptom, Sepsis, Sleep disorder, Sleep disorder therapy, Somnolence, Stress, Swelling, Transaminases increased, Transient ischaemic attack, Tremor, Thrombosis, Troponin increased, Ulcer, Upper respiratory tract infection, Drug ineffective, Analgesic therapy, Antacid therapy, Anticoagulant therapy, Drug therapy, Incorrect route of product administration, Intentional product misuse, Off label use, Product dose omission issue, Product use in unapproved indication, |
||||
MESALAMINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DEXLANSOPRAZOLE, LANTHANUM CARBONATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MAGNESIUM OXIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 198 | 26906684 |
US |
62 | 1 |
Skin laceration, Blood glucose increased, Eye pruritus, Oropharyngeal pain, Asthma, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 199 | 26906720 |
PR |
64 | 1 |
Asthma, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 200 | 26906734 |
US |
63 | 2 |
Pemphigoid, Asthma, Oral mucosal blistering, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30